Loomis, Sayles & Company’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-85
Closed -$10K 993
2023
Q4
$10K Sell
85
-23
-21% -$2.29K ﹤0.01% 795
2023
Q3
$10K Buy
108
+60
+125% +$6.19K ﹤0.01% 787
2023
Q2
$5K Sell
48
-57
-54% -$6.03K ﹤0.01% 869
2023
Q1
$11K Sell
105
-45
-30% -$4.7K ﹤0.01% 832
2022
Q4
$17K Sell
150
-25
-14% -$2.62K ﹤0.01% 738
2022
Q3
$15K Buy
175
+150
+600% +$13.6K ﹤0.01% 642
2022
Q2
$2K Hold
25
﹤0.01% 904
2022
Q1
$2K Buy
+25
New +$2.4K ﹤0.01% 980
2021
Q4
Sell
-107
Closed -$13K 920
2021
Q3
$13K Buy
+107
New +$13.8K ﹤0.01% 760
2013
Q3
Sell
-642
Closed -$17 772
2013
Q2
$17 Buy
+642
New +$17.7K ﹤0.01% 706

Other funds holding XYL

Loomis, Sayles & Company's XYL Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Xylem (XYL) in Q1 2024, closing a stake of 85 shares — an estimated $10K sold.

Loomis, Sayles & Company first reported a position in XYL in Q2 2013 and held it in 10 quarters. The position peaked at $17K in Q4 2022. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining Xylem position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 85 Xylem shares in Q1 2024, an estimated $10K.
  • Loomis, Sayles & Company first reported a position in Xylem in Q2 2013 and held it in 10 quarters.
  • Loomis, Sayles & Company's Xylem position peaked at $17K in Q4 2022.
  • 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.